BlackRock Advisors’s Celgene Corp CELG Stock Holding History

BlackRock Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$281M	Buy	2,426,361 +400,801	+20%	+$44.6M	0.28%	83
2016 Q3	$212M	Sell	2,025,560 -183,564	-8%	-$19.9M	0.22%	115
2016 Q2	$218M	Sell	2,209,124 -1,830,019	-45%	-$189M	0.22%	106
2016 Q1	$404M	Buy	4,039,143 +422,771	+12%	+$43.5M	0.42%	53
2015 Q4	$433M	Buy	3,616,372 +30,629	+0.9%	+$3.54M	0.46%	52
2015 Q3	$388M	Buy	3,585,743 +1,391,238	+63%	+$173M	0.42%	62
2015 Q2	$254M	Sell	2,194,505 -265,286	-11%	-$30.3M	0.26%	98
2015 Q1	$284M	Sell	2,459,791 -323,174	-12%	-$38.6M	0.29%	88
2014 Q4	$311M	Buy	2,782,965 +1,567	+0.1%	+$165K	0.31%	78
2014 Q3	$264M	Sell	2,781,398 -220,498	-7%	-$19.9M	0.26%	94
2014 Q2	$258M	Sell	3,001,896 -84,488	-3%	-$6.43M	0.24%	107
2014 Q1	$215M	Sell	3,086,384 -1,489,774	-33%	-$118M	0.21%	121
2013 Q4	$387M	Sell	4,576,158 -1,739,198	-28%	-$138M	0.37%	66
2013 Q3	$487M	Buy	6,315,356 +849,332	+16%	+$59.5M	0.49%	49
2013 Q2	$320M	Buy	+5,466,024	New	+$329M	0.34%	74

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Advisors's CELG Position: Q4 2016 in Review

BlackRock Advisors increased its Celgene Corp (CELG) stake by 20% in Q4 2016, buying an estimated $44.6M and bringing the position to 2,426,361 shares worth $281M. The position accounts for 0.28% of the portfolio, ranked #83.

BlackRock Advisors first reported a position in CELG in Q2 2013 and has held it in 15 quarters since. The position peaked at $487M in Q3 2013. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

BlackRock Advisors held 2,426,361 shares of Celgene Corp worth $281M as of Q4 2016.
BlackRock Advisors bought 400,801 Celgene Corp shares in Q4 2016, an estimated $44.6M.
Celgene Corp made up 0.28% of BlackRock Advisors's portfolio in Q4 2016, its #83 holding.
BlackRock Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Celgene Corp position peaked at $487M in Q3 2013.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.